New York Senate bill in Session 2025-2026.
Status: in_committee. Latest action: January 7, 2026.
Relates to the availability of opioid reversal agents.
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
| Date | Event | Detail |
|---|---|---|
| 2025-02-03 | Introduced | Bill introduced |
| 2026-01-07 | Status | in_committee |
| 2026-01-07 | Latest Action | In Senate Committee |